Provided by Tiger Trade Technology Pte. Ltd.

AQR Capital Holdings

2,627.98
-9.7405-0.37%
Number of Gainers:38
Number of Losers:58
Number of Flat:2
PE:- -
High:2,638.23
Open:2,637.37
Low:2,610.64
Close:2,637.59
Volume:326.01M
Turnover:71.93B
Market Cap:48.08T
Float Cap:44.70T

Loading ...

Moonshot AI seeks up to 30% revenue share from major cloud providers for its Kimi models

Deep News
·
Yesterday

Intel (INTC) Is A Key Vendor In The 5G Edge Cloud Market

Simply Wall St.
·
Yesterday

Alibaba’s AI-Focused Share Sale And Insider Buying Could Be A Game Changer For Alibaba Group (BABA)

Simply Wall St.
·
Yesterday

Does Adding Qualcomm’s Akash Palkhiwala to the Board Sharpen Applied Materials’ AI Strategy Narrative (AMAT)?

Simply Wall St.
·
Yesterday

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Yesterday

RBC Raises Price Target on Visa to $466 From $412, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

Colgate-Palmolive India Announces Resignation of Internal Auditor

TIPRANKS
·
Yesterday

Adobe to Provide Free AI Creative Tools to Saudi Citizens, Residents

MT Newswires Live
·
Yesterday

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Yesterday

AMD, Cisco, Humain Expand Saudi AI Joint Venture, Target 1 GW Capacity by 2030

Reuters
·
Yesterday

Advanced Micro Devices - Co, Cisco and Humain Joint Venture on Track to Deploy up to 1 Gw AI Infrastructure by 2030

THOMSON REUTERS
·
Yesterday

Amd, Cisco and Humain Expand Saudi Arabia’s AI Infrastructure as Amd Instinct Systems Go Live

THOMSON REUTERS
·
Yesterday

Model YL rear suspension failures plague owners as Tesla juggles record deliveries with slumping profits

Deep News
·
Yesterday

RBC Raises Price Target on PayPal Holdings to $70 From $65, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

Update: Market Chatter: SK Hynix Denies Report of Intel Foundry Partnership for HBM4E

MT Newswires Live
·
Yesterday

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Yesterday

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Yesterday

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Yesterday

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Yesterday

Dow Jones Top Company Headlines at 7 am ET: Aon Strikes Roughly $17 Billion Deal for Insurance Brokerage USI | GameStop ...

Dow Jones
·
Yesterday